TER vs ZYME · P/E 76, rev $2.82B vs rev $76.3M
Teradyne Inc (TER) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Teradyne Inc (TER) is a semiconductor equipment & materials company listed on NASDAQ.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported TER revenue for 2024-12-31 was $2.82B. Net income was $542.4M. Revenue was up 5.4% from 2023-12-31 to 2024-12-31. TER currently screens at market cap $63.96B and trailing P/E 75.7.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
TER currently screens at market cap $63.96B and trailing P/E 75.7. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the TER and ZYME stock pages for the full models.
Not investment advice.